Greatest Interview with Arthur Hayes.

38-year-old Arthur Hayes who hails from Detroit, with a estimated net worth of $500 million, and has posted a fantastic interview. It's...

Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can...

Khan Academy’s AI Pilot Program.

Learn About the Launch of Khan Academy's AI Pilot Program on Bloomberg Radio. Sal...

Hidden Gem and a Monster in the Making? Beasley Broadcast Group (BBGI) $0.80

If They Simply Changed Their Name to Beasley Internet Group, it Could be Revalued 3-Fold Higher. We...

Smart for Life (SMFL) Featured by New to the Street

Interviews to Air on National Television Including Bloomberg and Fox Business MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Smart...

Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.

Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....
Courtesy Ben Mills

Glutathione: The “Mother” of all Antioxidants…

Glutathione, also known as GSH, is a molecule found naturally in your body. It is produced by the liver and nerve cells...

Stand Down. “A Super Bubble” says Jeremy Grantham, the “Day of Reckoning is Here”...

Calling a Super Bubble. | Front Row with Jeremy Grantham https://youtu.be/JlEGU2ypr1Q

Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)

Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...

Nautilus (NLS) $8.50, Numbers Out. Time to go Bottom Fishing?

Adding Nautilus to the Watch List. Conference Call Transcript Below New Street Targets at $15 per Share.

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...